Corcept
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (59)
A Study of the Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas
Started: 7/27/2020
A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome
Started: 11/15/2018
Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer
Started: 6/29/2022
Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Started: 6/30/2020
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Started: 3/1/2008
Mifepristone in Children With Refractory Cushing's Disease
Started: 8/1/2013
An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Started: 7/1/2009
Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
Started: 11/1/2010
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
Started: 1/27/2026
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Started: 4/11/2025
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
Started: 11/15/2022
A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)
Started: 10/25/2023
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Started: 5/7/2018
Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Started: 4/5/2019
A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications
Started: 12/4/2019
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)
Started: 9/9/2020
Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Participants With Presumed Nonalcoholic Steatohepatitis (NASH)
Started: 11/4/2020
Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
Started: 6/1/2016
Evaluating the Pharmacokinetics and Safety of Miricorilant
Started: 4/30/2026
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
Started: 1/16/2026
Evaluation of Miricorilant on Liver Fat in Patients With MASLD
Started: 8/22/2025
Study Evaluating the Bioavailability of Miricorilant With Optional Food Effect Assessment in Healthy Adult Subjects
Started: 9/11/2025
Impact of Itraconazole on the Pharmacokinetics and Safety of Dazucorilant in Healthy, Adult Participants
Started: 5/31/2024
Effects of Hepatic Impairment on the Pharmacokinetics of Dazucorilant
Started: 10/8/2024
Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Miricorilant
Started: 3/3/2022
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)
Started: 11/23/2021
Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)
Started: 9/30/2020
A Study to Evaluate the Pharmacokinetics of the Current Capsule Formulation of CORT125134 in Healthy Subjects
Started: 5/18/2017
A Study to Evaluate the Pharmacokinetics of the CORT125134 Phase 2 Formulation in Healthy Male Subjects
Started: 4/7/2016
A Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Relacorilant
Started: 1/6/2020
A Study to Evaluate the Effect of Food on the Oral Bioavailability of Relacorilant in Healthy Subjects
Started: 9/19/2020
Study to Evaluate Exicorilant (CORT125281) in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer
Started: 2/20/2018
Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of Miricorilant
Started: 1/24/2023
Single and Multiple Ascending Dose Study of CORT125236 in Healthy Participants
Started: 8/3/2021
Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants
Started: 5/25/2022
Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid Tumors
Started: 5/23/2016
Single and Multiple Ascending Dose Study of CORT125329 in Healthy Participants
Started: 10/23/2020
A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers
Started: 11/1/2008
Single and Multiple Ascending Dose Study of CORT113176 in Healthy Participants
Started: 1/27/2020
Single Dose Absorption, Distribution, Metabolism, and Excretion Study of [14C]-CORT113176 in Healthy Male Participants
Started: 8/18/2021
Safety, Tolerability, and Pharmacokinetic Study of CORT113176 in Healthy Participants
Started: 7/13/2021
T/QT Study to Investigate the Effect of Relacorilant on Cardiac Repolarization in Healthy Volunteers
Started: 1/22/2021
Single and Multiple Dose Study of Miricorilant (CORT118335) Tablet Formulations in Healthy Participants
Started: 4/27/2020
The Effect of CORT118335 on Olanzapine-Induced Weight Gain
Started: 4/1/2019
Study in Healthy Subjects to Determine the Effect of an Inhibitor on Exposure to Relacorilant and Its Metabolites
Started: 4/10/2018
A Study Designed to See How [14C]-CORT125134 is Taken up, Broken Down and Removed From the Body
Started: 8/1/2016
CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)
Started: 9/1/2014
Absolute Bioavailability and Metabolism Study of CORT118335 in Healthy Male Participants
Started: 8/6/2018
Mass Balance Recovery and Metabolite Profile of CORT125281 in Healthy Male Participants
Started: 9/13/2018
A Study to Determine the Relative Bioavailability of Two New Relacorilant Capsule Variants
Started: 5/24/2018
CORT125281 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)
Started: 9/21/2017
Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s
Started: 3/6/2018
Crossover Drug-Drug Interaction Study to Determine Effects of Cytochrome P450 3A on Exposure to Mifepristone and Its Metabolites
Started: 8/16/2017
Mifepristone Drug-Drug Interaction Study With CYP3A Inhibitor
Started: 8/9/2017
Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors
Started: 1/1/2014
A Phase I Study to Determine the Effect of Mifepristone on the Pharmacokinetics of Fluvastatin in Healthy Volunteers
Started: 9/1/2008
Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)
Started: 3/31/2023